Topiramate: A case series study in migraine prophylaxis

Cephalalgia

Volumn 22, Issue 8, 2002, Pages 659-663

  Young, William B ^a,b   Hopkins, M M ^a   Shechter, A L ^a   Silberstein, S D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Chronic migraine; Migraine; Outcomes; Topiramate

Indexed keywords

PLACEBO; TOPIRAMATE; DRUG DERIVATIVE; FRUCTOSE; NEUROPROTECTIVE AGENT;

ADULT; APPETITE DISORDER; ARTHRALGIA; CLUSTER HEADACHE; COGNITIVE DEFECT; COLD LIMB; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIGRAINE; NAUSEA; NEUROPROTECTION; NIGHTMARE; OUTCOMES RESEARCH; PARESTHESIA; PROPHYLAXIS; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; THORAX PAIN; TREMOR; VERTIGO; VISUAL IMPAIRMENT; WEIGHT GAIN; ADOLESCENT; ARTICLE; CHILD; METHODOLOGY; MIDDLE AGED; PREVENTIVE MEDICINE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; PREVENTIVE MEDICINE; TREATMENT OUTCOME;

EID: 0036781473     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00380.x     Document Type: Review

References (24)

1. Galvez-Jimenez N, Hargreave M. Topiramte and essential tremor. Ann Neurol 2000; 47:837-8.
2. Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disorders 1999; 1:42-53.
3. Chengappa R, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. J Assoc Eur Psychiatrists 2001; 16:2001.
4. Marcotte D. Use of topiramate, a new antiepileptic as a mood stabilizer. J Affective Disorders 1998; 50:245-51.
5. McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, et al. Open label adjunctive topiramate in the treatment of bipolar disorders. Bio Psychiatry 2000; 47:1025-33.
6. Grunze HC, Normarnn C, Langosch J, Schaefer M, Amann B, Sterr A et al. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry 2001; 62:464-8.
7. Potter DL, Hart DE, Calder CS, Storey JR. A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine. Neurology 2000; 54:A15 (Abstract).
8. Edwards KR, Glantz MJ, Shea P, Norton JA, Cross N. A double-blind, randomized trial of topiramate versus placebo in the prophylactic treatment of migraine headache with and without aura. Cephalalgia 2000; 20:316 (Abstract).
9. Goggins P, Niebauer M, Gruenthal M. Neuroprotective effects of AEDs and other compounds: limbic status epilepticus. 1998; (Unpublished).
10. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacol 2000; 39:881-8.
11. Koh S, Jensen FE. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann Neurol 2001; 50:366-72.
12. Von Seggern RL, Mannix LK, Adelman JU. Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Neurology 2000; 54:A267-A268 (Abstract).
13. Ahmad F, Shuaib A, Kochanski F, Maratoglu M. Effectiveness of topiramate in prophylaxis of migraine. Can J Neuro Sci 1999; 260 (Suppl. 30): (Abstract).
14. vonSeggern RL, Adelman JU, Mannix LK. A retrospective chart review demonstrating the efficacy of topiramate for prophylaxis of migraine. Cephalalgia 2001; 21:369 (Abstract).
15. Mathew NT, Kailasam J, Fischer A. Prophylaxis of migraine with topiramate: a retrospective analysis. Cephalalgia 2001; 21:370 (Abstract).
16. Krusz JC. Topiramate: effective prophylaxis treatment for refractory migraines and mixed headaches. Cephalalgia 2001; 21:371 (Abstract).
17. Wheeler SD, Carrazana EJ. Topiramate is indicated in cluster-migraine. Cephalalgia 2001; 21:371 (Abstract).
18. Edwards KR, Khoury KN, Cross NE, Lewis CA, Norton JA. Long-term therapy with topiramate reduces migraine frequency and severity: a retrospective chart analysis. Cephalalgia 2001; 21:372 (Abstract).
19. Brandes JL, Hatfield R, Roberson S, Dixon B. Neuromodulation of late life migrainous accompaniments with topiramate therapy. Cephalalgia 2001; 21:372 (Abstract).
20. Krusz JC, Scott V. Topiramate in the treatment of chronic migraine and other headaches. Headache 1999; 39:363 (Abstract).
21. Storey JR, Cader CS, Potter DL. Potential role of topiramate in the treatment of intractable headache: a retrospective pilot study. Neurology 1999; 52:A211 (Abstract).
22. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47:871-5.
23. Curioso EP, Young WB, Shechter AL, Kaiser RS. Psychiatric comorbidity predicts outcome in chronic daily headache patients. Neurology 1999; 52:A471 (Abstract).
24. Young WB, Hopkins MM, Sanchez Del Rio M, Shechter AL. The effect of topiramate on weight in chronic daily headache and episodic migraine patients. Conference Proceeding from the Migraine Trust Meeting in London, 2000.